期刊文献+

老年BPH与代谢综合征关系的临床研究 被引量:1

Clinical study of correlation between BPH and metabolic syndrome in elderly
原文传递
导出
摘要 目的:探讨代谢综合征与BPH的相关性。方法:将伴有下尿路症状的246例老年BPH患者根据有无代谢综合征分成两组:Ⅰ组伴有代谢综合征患者139例,Ⅱ组不伴代谢综合征患者107例,测量体质指数(BMI)、血压、腰围,根据下尿路症状进行国际前列腺症状评分(IPSS)。所有患者检查空腹血糖(FBG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、空腹胰岛素水平(FINS)、糖化血红白水平(HbA1c)、餐后血糖(PBG)及前列腺特异抗原(PSA),计算胰岛素抵抗指数(HOMA-IR)。经腹部超声测量前列腺三径计算前列腺体积(PV)。结果:老年BPH患者高血压、冠心病、糖尿病的患病率高,代谢综合征组患者BMI、SBP、FBG、PBG、LDL-C、TG、FINS、HbA1c及PV较对照组显著升高,且存在胰岛素抵抗,差异具有统计学意义(P<0.05)。结论:老年BPH患者存在胰岛素抵抗,研究表明代谢综合征可能促进BPH。因此,改善胰岛素抵抗可能对预防BPH有一定作用。 Objective:To investigate the correlation between metabolic syndrome and benign prostatic hyperpla- sia (BPH). Method:Two hundred and forty-six BPH patients with lower urinary symptoms were divided into two groups according to whether they had metabolic syndrome. There were 139 cases with metabolic syndrome in group Ⅰ while 107 cases without metabolic syndrome in group Ⅱ. Blood pressure, the body mass index (BMI) and waist circumference were measured. All the patients were evaluated by International Prostate Symptom Score (IPSS). Biochemical analyses including fasting blood glucose (FBG), two hours postprandial blood glucose (PBG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), fasting insulin (FINS), glycated hemoglobin (HbAlc) and prostate-specific antigen (PSA) were measured and insulin resistance (HOMA-IR) were calculated. Prostate volume (PV) was measured by abdominal ultra- sound. Result:Elderly with BPH had higher incidence of hypertension, diabetes, as well as coronary artery dis- ease. The indices of BMI, SBP, FBG, PBG, LDL-C, TG, FINS, HbAlc and PV were significantly higher in metabolic syndrome group. There were significant differences between the two groups (P〈0.05). Conclusion:The present study demonstrates that insulin resistance can be seen in elderly with BPH. The metabolic syndrome may contribute to the development of BPH. Thus, decreasing insulin resistance may prevent the occurrence of BPH.
出处 《临床泌尿外科杂志》 2013年第12期932-934,共3页 Journal of Clinical Urology
关键词 良性前列腺增生 代谢综合征 胰岛素抵抗 benign prostatic hyperplasia metabolic syndrome insulin resistance
  • 相关文献

参考文献11

  • 1贾伟平.中国人群胰岛素抵抗的状况[J].国外医学(内分泌学分册),2002,22(4):264-264. 被引量:104
  • 2Ford E S, Giles W H, Dietz W H. Prevalence of the metabolic syndrome among US adults- findings from the third National Health and Nutrition Examination Survey [J]. JAMA, 2002, 287(3):356-359.
  • 3Xie L P, Bai Y, Zhang X Z, et al. Obesity and benign prostatic enlargement A large observational study in Chi- na[J]. Urology, 2007, 69(4):680-684.
  • 4Ozden C, Ozdal O 1, Urganeioglu G, et al. The correla- tion between metabolic syndrome and growth in patients with benign prostatic hyperplasia[J]. Eur Urol, 2007, 51(1): 199-203.
  • 5Nandeesha H, Koner B C, Dorairajan L N, et al. Hy- perinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J]. Clin Chin A cta, 2006, 370(1 -2): 89-93.
  • 6何家扬,王伟.代谢综合征与前列腺增生症[J].现代泌尿外科杂志,2009,14(2):81-83. 被引量:9
  • 7高新,庞俊.老年人良性前列腺增生症与内科疾病[J].中华老年医学杂志,2006,25(6):474-476. 被引量:10
  • 8Berger A P, Deib I M, Leonhartsberger N, et al. Vas- cular damage as a risk factor for benign prostatic hyper- plasia and erectile dysfunction[J]. BJU Int, 2005, 96 (7): 1073-1078.
  • 9Vikram A, Jena G B, Ramarao P. Increased cell prolif- eration and contractility of prostate in insulin resistant rats Linking hyperinsulinemia with benign prostate hy perplasia[J]. Prostate, 2010, 70(1): 79-89.
  • 10Neuhouser M L, Schenk J, Song Y J, et al. Insulin-like growth factor-1 insulinqike growth factor binding pro- rein-3 and risk of benign prostate hyperplasia in the pros- tate cancer prevention trial[J]. Prostate, 2008, 68(13): 1477-1486.

二级参考文献14

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3044
  • 2OZDEN C, OZDAL OL, URGANCIOGLU G, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia [J]. Eur Urol, 2007, 51(1) :199-206.
  • 3HAMMASTEN J, HOGSTED B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia [J ]. Eur Urol, 2001, 39(2):151-158.
  • 4NANDEESHA H, KONER BC, DORAIRAJAN LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia[J]. Clinica Chimica Acta, 2006,370(1-2) :89-93.
  • 5BURKE JP, JACOBSON DJ, MCGREE ME, et al. Diabetes and benign prostatic hyperplasia progression in Olmsted county, Minnesota[J]. Urology, 2006,67(1) : 22-25.
  • 6SOURIJ H, SCHMOELZER I, DITTRICH P, et al. Insulin resistance as a risk factor for carotid atherosclerosis:a comparison of the Homeostasis Model Assessment and the short insulin tolerance test [J]. Stroke, 2008, 39(4) :1349-1351.
  • 7LEE S, MIN HG, CHOI SH, et al. Central obesity as a risk factor for prostatic hyperplasia [J]. Obesity, 2006,14 (1):172- 179.
  • 8KASTURI S, RUSSELL S, MCVARY KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia [J].Curr Urol Rep, 2006,7 (4) : 288-292.
  • 9ALBERTI KG, ZIMMET P, SHAW J, et al. The metabolic syndrome-- a new worldwide definition[J]. Lancet, 2005, 366 (9491) : 1059-1062.
  • 10BALKAU B, ESCHWEGE E. The metabolic syndrome [J]. Lancet, 2005, 366(9501) :1921.

共引文献119

同被引文献37

  • 1Parsons J K,Carter H B,Partin A W,et al.Metabolic factors associated with benign prostatic hyperplasia[J].J Clin Endocrinol Metab,2006,91(7):2562-2568.
  • 2Kristal A R,Arnold K B,Schenk J M,et al.Race/ethnicity,obesity,health related behaviors and the risk of symptomatic benign prostatic hyperplasia:results from the prostate cancer prevention trial[J].J Urol,2007,177(4):1395-1400;quiz 1591.
  • 3Parsons J K,Messer K,White M,et al.Obesity increases and physical activity decreases lower urinary tract symptom risk in older men:the Osteoporotic Fractures in Men study[J].Eur Urol,2011,60(6):1173-1180.
  • 4Motoya T,Matsumoto S,Yamaguchi S,et al.The impact of abdominal aortic calcification and visceral fat obesity on lower urinary tract symptoms in patients with benign prostatic hyperplasia[J].Int Urol Nephrol,2014,46(10):1877-1881.
  • 5Wang H H,Hsieh C J,Lin K J,et al.Waist circumference is an independent risk factor for prostatic hyperplasia in Taiwan Residents males[J].Asian J Surg,2011,34(4):163-167.
  • 6Antunes A A,Araújo L H,Nakano E,et al.Obesity may influence the relationship between sex hormones and lower urinary tract symptoms[J].Int Braz J Urol,2014,40(2):240-246.
  • 7He Q,Wang H,Yue Z,et al.Waist circumference and risk of lower urinary tract symptoms:a meta-analysis[J].Aging Male,2014:1-7.
  • 8Lee R K,Chung D,Chughtai B,et al.Central obesityas measured by waist circumference is predictive of severity of lower urinary tract symptoms[J].BJU Int,2012,110(4):540-545.
  • 9Xie L P,Bai Y,Zhang X Z,et al.Obesity and benign prostatic enlargement:a large observational study in China[J].Urology,2007,69(4):680-684.
  • 10Berges R,Oelke M.Age-stratified normal values for prostate volume,PSA,maximum urinary flow rate,IPSS,and other LUTS/BPH indicators in the German male community-dwelling population aged 50years or older[J].World J Urol,2011,29(2):171-178.

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部